Sentence examples for are still efficacious from inspiring English sources

Surprisingly, MSCs are still efficacious in ameliorating FHF in splenectomized mice.

route was still efficacious against severe influenza virus infections without any of the negative side effects associated with oral or intravenous administration (Gilbert and McLeay, 2008).

Our experimental design reproduced the worst-case scenario for evaluating the effect of vaccination and, under such conditions; it was still efficacious in slowering PRRSV transmission and decreasing the global viral load and particularly oral shedding.

These data suggest that pyrazinamide treatment is still efficacious after 2 months of treatment and suggests that the observed bactericidal synergy with J [33] is extended in the sterilizing phase.

Nevertheless, the middle school students' gains were significant, indicating that the game was still efficacious at the middle school level in terms of students acquiring new science knowledge.

If there is still no resistance to the partner drug, it is assumed that ACTs kill parasites effectively and this results in a 99.999% reduction in the artemisinin-sensitive parasite population and a 99.9% reduction in the artemisinin-resistant parasite population (as the partner drug is still efficacious).

In contrast, the DMO for Mkuranga viewed that SP was still efficacious and safe if timely and appropriately used, in spite of the evidence available that its efficacy against P.falciparum malaria was continuing to decrease in many places in the country.

Controlled clinical trials are still necessary to explore the various efficacious antifungal combinations [ 17].

They seem to indicate that the conventional way of distributing the measurement points is far more efficient than placing the points at random, and that continuous averaging is still more efficacious.

Therefore, there is still no efficacious cell therapy-based treatment for muscle diseases.

But such discoveries are still a long way from safe and efficacious drugs, and GSK's late-stage pipeline remains weak.